ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Lung Cancer trials near Austin, TX, USA:

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

Austin, Texas, United States and 30 other locations

The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Su ...

Enrolling
Resectable Non-Small-Cell Lung Cancer
Lung Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Gilead Sciences
Gilead Sciences

Austin, Texas, United States and 82 other locations

New

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...

Begins enrollment this month
Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Drug: Pembrolizumab

Phase 3

AstraZeneca
AstraZeneca

Round Rock, Texas, United States and 219 other locations

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Durvalumab
Procedure: Surgery

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 230 other locations

Locations recently updated

This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: sigvotatug vedotin
Drug: docetaxel

Phase 3

Seagen
Seagen

Austin, Texas, United States and 140 other locations

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...

Active, not recruiting
Advanced Non Small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Drug: Docetaxel
Drug: MRTX849

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Austin, Texas, United States and 262 other locations

with locally advanced or metastatic non-squamous Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) ex...

Enrolling
Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
Drug: platinum-based chemotherapy
Drug: furmonertinib 240 mg oral, daily

Phase 3

ArriVent BioPharma
ArriVent BioPharma

Austin, Texas, United States and 206 other locations

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer...

Enrolling
Non Small Cell Lung Cancer
Drug: Docetaxel
Biological: Telisotuzumab Vedotin

Phase 3

AbbVie
AbbVie

Austin, Texas, United States and 285 other locations

in participants with chemotherapy-naive extensive-stage small cell lung cancer (ES-SCLC). Eligible participants will be stratified ...

Active, not recruiting
Small Cell Lung Cancer
Drug: Etoposide
Drug: Tiragolumab

Phase 3

Roche
Roche

Austin, Texas, United States and 123 other locations

plus Etoposide to that of Atezolizumab with Carboplatin plus Etoposide as First-Line Therapy in Participants with Extensive-Stage Small Cell Lung...

Begins enrollment in 2 months
Extensive-Stage Small Cell Lung Cancer
Drug: Carboplatin
Drug: Etoposide

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Austin, Texas, United States and 151 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems